Carbocyclic nucleoside reverse transcriptase inhibitors

The present invention is directed carbocyclic nucleoside reverse transcriptase inhibitors compounds of Formula Iand their use in the inhibition of HIV reverse transcriptase, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Rahali, Rachid, Raheem, Izzat, Parsy, Christophe, Alexandre, Francois-Rene
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Rahali, Rachid
Raheem, Izzat
Parsy, Christophe
Alexandre, Francois-Rene
description The present invention is directed carbocyclic nucleoside reverse transcriptase inhibitors compounds of Formula Iand their use in the inhibition of HIV reverse transcriptase, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS and/or ARC.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US11040975B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US11040975B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US11040975B23</originalsourceid><addsrcrecordid>eNrjZDB3TixKyk-uTM7JTFbIK03OSc0vzkxJVShKLUstKk5VKClKzCtOLsosKEkE8jLzMjKTMkvyi4p5GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakl8aLChoYGJgaW5qZORMTFqAEHfLws</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Carbocyclic nucleoside reverse transcriptase inhibitors</title><source>esp@cenet</source><creator>Rahali, Rachid ; Raheem, Izzat ; Parsy, Christophe ; Alexandre, Francois-Rene</creator><creatorcontrib>Rahali, Rachid ; Raheem, Izzat ; Parsy, Christophe ; Alexandre, Francois-Rene</creatorcontrib><description>The present invention is directed carbocyclic nucleoside reverse transcriptase inhibitors compounds of Formula Iand their use in the inhibition of HIV reverse transcriptase, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS and/or ARC.</description><language>eng</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210622&amp;DB=EPODOC&amp;CC=US&amp;NR=11040975B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210622&amp;DB=EPODOC&amp;CC=US&amp;NR=11040975B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Rahali, Rachid</creatorcontrib><creatorcontrib>Raheem, Izzat</creatorcontrib><creatorcontrib>Parsy, Christophe</creatorcontrib><creatorcontrib>Alexandre, Francois-Rene</creatorcontrib><title>Carbocyclic nucleoside reverse transcriptase inhibitors</title><description>The present invention is directed carbocyclic nucleoside reverse transcriptase inhibitors compounds of Formula Iand their use in the inhibition of HIV reverse transcriptase, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS and/or ARC.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB3TixKyk-uTM7JTFbIK03OSc0vzkxJVShKLUstKk5VKClKzCtOLsosKEkE8jLzMjKTMkvyi4p5GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakl8aLChoYGJgaW5qZORMTFqAEHfLws</recordid><startdate>20210622</startdate><enddate>20210622</enddate><creator>Rahali, Rachid</creator><creator>Raheem, Izzat</creator><creator>Parsy, Christophe</creator><creator>Alexandre, Francois-Rene</creator><scope>EVB</scope></search><sort><creationdate>20210622</creationdate><title>Carbocyclic nucleoside reverse transcriptase inhibitors</title><author>Rahali, Rachid ; Raheem, Izzat ; Parsy, Christophe ; Alexandre, Francois-Rene</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US11040975B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Rahali, Rachid</creatorcontrib><creatorcontrib>Raheem, Izzat</creatorcontrib><creatorcontrib>Parsy, Christophe</creatorcontrib><creatorcontrib>Alexandre, Francois-Rene</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Rahali, Rachid</au><au>Raheem, Izzat</au><au>Parsy, Christophe</au><au>Alexandre, Francois-Rene</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Carbocyclic nucleoside reverse transcriptase inhibitors</title><date>2021-06-22</date><risdate>2021</risdate><abstract>The present invention is directed carbocyclic nucleoside reverse transcriptase inhibitors compounds of Formula Iand their use in the inhibition of HIV reverse transcriptase, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS and/or ARC.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US11040975B2
source esp@cenet
subjects ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Carbocyclic nucleoside reverse transcriptase inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T00%3A16%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Rahali,%20Rachid&rft.date=2021-06-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS11040975B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true